Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | 0.01% | 358.53 | 1.2% | $822.90m | |
| AMGN | Amgen Inc. | -0.58% | 191.68 | 1.2% | $548.86m | |
| CELG | Celgene Corporation | -0.18% | 85.63 | 1.2% | $541.37m | |
| GILD | Gilead Sciences, Inc. | 0.57% | 77.56 | 0.9% | $485.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.58% | 134.56 | 16.6% | $345.23m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.30% | 180.59 | 1.9% | $321.12m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.06% | 366.18 | 2.6% | $293.66m | |
| ILMN | Illumina, Inc. | 0.69% | 309.39 | 3.5% | $269.06m | |
| BLUE | Bluebird Bio, Inc. | 0.00% | 179.55 | 15.7% | $208.16m | |
| NKTR | Nektar Therapeutics | 1.75% | 48.72 | 5.6% | $178.51m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.39% | 135.12 | 2.0% | $175.72m | |
| FMI | Foundation Medicine, Inc. | 0.09% | 136.93 | 8.8% | $160.93m | |
| EXAS | Exact Sciences Corporation | 0.76% | 67.25 | 25.4% | $160.51m | |
| EXEL | Exelixis, Inc. | -0.09% | 21.31 | 6.4% | $135.64m | |
| A | Agilent Technologies, Inc. | 1.95% | 64.22 | 1.5% | $132.81m |
Company Profile
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.